Congratulations to PGY-5 Dr. @yesantharao on matching at @MSKCancerCenter for her Microsurgery Fellowship! 🎉
We're proud of all she has accomplished at Stanford and excited to see what comes next. Please join us in wishing her continued success! 👏
Stanford was represented across panels, scientific sessions, poster presentations, & innovation-focused programming throughout the @AAPS1921 meeting.
Congrats to Dr. Arash Momeni on receiving the James Barrett Brown Award 👏
Read the full INSIDE recap: https://t.co/MKaZG8DYJw
🏆 First place at IBSD 👏🏽
PGY-5 Dr. @yesantharao wins the IBSD Talent Challenge at the 14th International Breast Symposium Düsseldorf—the largest breast meeting in Europe. @breastmeeting@amomenimd also presented on microsurgical breast reconstruction as invited faculty.
💡 New from Drs. @amomenimd and @yesantharao: A frontline-led “Cost Savings Reinvestment Program” empowered physicians to drive over $34M in validated savings—yielding a 13x ROI.
🔗: https://t.co/6OpVEzySWw
👩⚕️👨⚕️ Get ready! Next week our residents will be taking over our socials to give you a behind-the-scenes look at life in Plastic Surgery across Stanford, SCVMC, the VA, and more.
📅 Follow along Aug 25–29 as each day a different resident shares their journey and perspective. 🎥
🚨 New Release! 🚨
#PRSGlobalOpen & @aaps1921 present top abstracts from the AAPS 103rd Annual Meeting. Discover cutting-edge #plasticsurgery research! 🔗 https://t.co/3pOZSjX6yU
#AAPS2025
New from @amomenimd in @prsjournal: First RCT in plastic surgery shows apixaban is as safe as enoxaparin for VTE prevention after autologous breast reconstruction—no VTE events, equal bleeding risk, & it's oral with no injections or monitoring needed.
🔗: https://t.co/87vIOvTK3S
🏆 Graduation Awards Night Highlights 🏆
As part of our graduation celebration, we recognized excellence across research, education, and clinical training. Congratulations to all our award recipients!
🔬 Research from Drs. Rahim Nazerali & @yesantharao finds extended antibiotic prophylaxis beyond a single pre-op dose of cefazolin does not reduce infection risk in second-stage breast recon. Overuse may lead to unnecessary side effects & resistance.
🔗: https://t.co/je2H61SABS
🏆Congrats to resident Dr. @yesantharao & faculty Dr. @amomenimd who won the best overall paper at #ASRM2025 for their project: VTE Chemoprophylaxis in Plastic Surgery: A Randomized Trial of Apixaban vs. Enoxaparin. 🎉
#ASRM2025
In the spirit of the holiday season, unwrap🎁 and read these 3 great articles featured in the December 2024 PRS!
🍩The Donut DIEP Flap:https://t.co/Af0TeMN9TP
🎄Tree-Based Reinforcement:
https://t.co/iORV5INykY
🤖From Data to Decisions
https://t.co/DsNKkCyNF6
Happy Holidays!